US Antibody Drug Conjugate Market
US Antibody Drug Conjugate Market Research Report By Type (Cytotoxic Drug Conjugates, Immunomodulatory Drug Conjugates, Radiolabeled Drug Conjugates, Dual Action Drug Conjugates), By Therapeutic Area (Oncology, Autoimmune Diseases, Infectious Diseases, Neurological Disorders), By Mechanism of Action (Targeted Delivery, Cell Cycle Disruption, Immune Modulation, Antibody-Dependent Cellular Cytotoxicity) and By Route of Administration (Intravenous, Subcutaneous, Intramuscular) - Forecast to 2035
US Antibody Drug Conjugate Market Overview
As per MRFR analysis, the US Antibody Drug Conjugate Market Size was estimated at 1.77 (USD Billion) in 2023. The US Antibody Drug Conjugate Market Industry is expected to grow from 1.95(USD Billion) in 2..